Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Asperosaponin VI is a triterpenoid saponin that has been found in D. asper and has diverse biological activities.1,2,3 It increases bone morphogenetic protein 2 (BMP2) levels in, and induces differentiation of, MC3T3-E1 mouse preosteoblasts in a concentration-dependent manner.1 It also inhibits osteoclast formation induced by RANKL in vitro and reduces joint inflammation and bone loss in a mouse model of collagen-induced arthritis when administered at a dose of 20 mg/kg.2 Asperosaponin VI (150 and 450 mg/kg) reduces increases in acetic acid-induced vascular permeability and increases the latency to paw withdrawal in the hot plate test in mice.3
WARNING This product is not for human or veterinary use.
1. Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-
2. Asperosaponin VI protects against bone destructions in collagen induced arthritis by inhibiting osteoclastogenesis. Phytomedicine 63, 153006 (2019).
3. Anti-